Cut the Chat Life Science Insider
Seuss+
Publishing Details
About This Podcast
An informative podcast series designed quite literally cut the unnecessary talk and get straight to the point and heart of many life science and Biotech conversations that need to happen for our industry to evolve, innovate and get smarter—faster.
We’ll facilitate the conversations you’ve been dying to hear and tackle the real crux of our industry’s challenges while addressing the subjects of what we can do as life science leaders to be more successful in a shorter period of time, conversations that might actually help each other when we dare to open up.
Hear directly from some visionary global biotech and life science leaders.
Podcasting 2.0 Features
Explore Statistics
Recent Episodes
S3E7 The Myth of Vendor Fit: How to Read RFPs Beyond the Polish
A practical conversation on how biotechs can read RFPs differently, avoid the fluency trap, challenge assumptions, and choose vendors that can actually deliver.Every biotech faces this moment: the…
S3E6 Beyond the Checklist: The Hidden Risks in Clinical Systems Compliance
Clinical systems compliance sounds like a box to tick, until the box breaks your trial.In this episode, Seuss+ CEO Kieran Engels and Lauren Alani, Director of Digital Innovation, reveal the blind…
S3E5 Quality as Culture: Why Biotechs Can’t Afford to Get It Wrong
Quality isn’t just a checkbox — it’s a biotech differentiator.What does “quality” really mean in biotech? And why does it so often get treated as a box to tick instead of a strategic advantage?In…
S3E4 Innovation, Execution, and Equity in RNA-Based Women’s Health
In this episode, Seuss+ CEO and Co-Founder Sabine Hutchison sits down with Klaas Zuideveld, CEO of Versameb, to discuss the scientific, clinical, and societal implications of RNA-based therapies…
S3E3 Inside the Bid: What Sponsors Need to Know About CRO Pricing, Pressure & Proposals
A look inside the proposal engine room - and how sponsors can rethink pricing, pressure, and partnership.Why do so many biotech sponsors feel blindsided by CRO proposals and change orders?In this…
S3E2 Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development
In this episode of The Life Science Insider, Kieran Canisius speaks with Limor Ben Har, COO of Prilenia Therapeutics, about what it takes to lead through complexity. Together they unpack the true…
S3E1 Two Questions, Zero Prep: What We’d Ask Each Other (If We Were the Guests)
The Life Science Insider is back with a brand-new video-first format — and this kickoff episode gets real fast.In this raw, unscripted premiere, Seuss+ Co-Founders and Co-CEOs Kieran Canisius and…
S2E4 AI in Biotech: Hype, Reality, and the Future of Drug Development
In this episode, Christina Busmalis and Sabine dive deep into the evolving intersection of AI and drug development. They explore the challenges and opportunities posed by digital endpoints, AI in…
S2E3 Transforming Clinical Trials: How Digital Endpoints Are Leading the Way
We explore the transformative potential of digital endpoints in clinical trials, emphasizing their role in revolutionizing data collection for patients, regulators, and payers. Despite the FDA's…
S2E2 Navigating the Commercialization Journey: Insights from Science to Market
In the second episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the dynamic Kirsten Detrick, whose extensive experience in biotech and pharma comes through in her…
S2E1 Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions
Sabine Hutchison talks to the inspiring investor Stephanie Oestreich.In the first episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the inspiring Stephanie…
S1E5 Mastering the Art of Collaboration: Principal Investigator and Biotech Dynamics
Sabine Hutchison sits down with the incredible Viviënne van de Walle a highly respected principal investigator who brings her wealth of experience to the table, blending clinical research with…
S1E4 Cross-Pollination and DEI Strategies with Ben Osborn
In Episode 4 of "Cut the Chat," host Sabine Hutchison engages in a thought-provoking discussion with Ben Osborn, a prominent figure in the biopharma industry and President of the Europe Eastern…
S1E3 Cracking the code: Navigating the Ever-Changing Biotech Landscape
Join Seuss+ CEO and Co-Founder Sabine Hutchison as she sits down with the accomplished Dr. Allison Jeynes-Ellis, a visionary leader whose journey spans medicine, oncology, and the life sciences. …
S1E2 Innovation Unleashed: Exploring the Intersection of Science and Creativity – An Unconventional Growth Strategy
Seuss+ CEO and Co-Founder Sabine Hutchison delves into the remarkable growth strategy and remarkable journey of Agenus Bio, a standout player in the competitive Biotech industry. This unique…
S1E1 Smart KPIs for Biotechs
Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits down with Sabine to discuss the importance of measuring what…
Frequently Asked Questions
Cut the Chat Life Science Insider has published 16 episodes since June 2023, covering topics in Health & Fitness, Life Sciences.
Cut the Chat Life Science Insider is currently moderate with new episodes monthly. Average episode length is 31m.
Similar Podcasts
The Kevin Miller Podcast
Kevin Miller | YAP Media
1,684 episodes
The Dr. Gabrielle Lyon Show
Dr. Gabrielle Lyon
210 episodes
EMS 20/20
Long Pause Media | FlightBridgeED
246 episodes
EM Clerkship
Zack Olson, MD ; Mike Estephan, MD ; Maddie Watts, MD
281 episodes
Psychedelics Today
Psychedelics Today
774 episodes
The Short Coat: An Inside Look at Getting Into and Getting Through Medical School
The Students of the University of Iowa Carver College of Medicine
400 episodes